Quantbot Technologies LP Stoke Therapeutics, Inc. Transaction History

Quantbot Technologies LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$7.07 - $15.69 $23,267 - $51,635	3,291 New	3,291 $30,000
Q2 2022 Aug 09, 2022	SELL	$10.36 - $23.93 $44,548 - $102,899	-4,300 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$17.19 - $26.1 $49,851 - $75,690	2,900 Added 207.14%	4,300 $90,000
Q4 2021 Feb 11, 2022	BUY	$18.11 - $30.72 $3,622 - $6,144	200 Added 16.67%	1,400 $33,000
Q3 2021 Nov 09, 2021	BUY	$23.65 - $34.44 $23,650 - $34,440	1,000 Added 500.0%	1,200 $30,000
Q3 2020 Nov 16, 2020	BUY	$22.23 - $37.48 $4,446 - $7,495	200 New	200 $6,000

117

55.6M

14K

8.8K

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $482M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.